Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Neoplasm Recurrence, Local × TP protocol × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Esophageal Squamous Cell Carcinoma 4 Esophageal Neoplasms 2 Uterine Cervical Neoplasms 1 Squamous Cell Carcinoma of Head and Neck 1 Neoplasms 1 Neoplasm Recurrence, Local 1 Neoplasm Metastasis 1 Endometrial Neoplasms 1 Carcinoma, Ductal, Breast 1

Interventions

Radiotherapy 2 tislelizumab 1 pembrolizumab 1 TP protocol 1 Paclitaxel 1 Lomustine 1 Cisplatin 1 Cetuximab 1 Carboplatin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06532539 2024-08-01

Cadonilimab With Chemoradiation for Recurrent and Oligometastatic Endometrial Carcinoma

Shandong Cancer Hospital and Institute

Phase 2 Recruiting

Neoplasm Metastasis, Neoplasm Recurrence, Local, Neoplasms, Endometrial Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡